The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
The UDP-glucuronosyltransferases: Their role in drug metabolism and detoxification
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tree View: An application to display phylogenetic trees on personal computers
Page, R. D. M. (1996) · Bioinformatics · doi:10.1093/bioinformatics/12.4.357 · Cited by 10,178
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
Pirmohamed, M., James, S., Meakin, S., Green, C., Scott, A. K., Walley, T. J., Farrar, K., Park, B. K., & Breckenridge, A. M. (2004) · BMJ · doi:10.1136/bmj.329.7456.15 · Cited by 3,230
Review on uremic toxins: Classification, concentration, and interindividual variability
Vanholder, R., For the European Uremic Toxin Work Group (EUTox), De Smet, R., Glorieux, G., Argilés, A., Baurmeister, U., Brunet, P., Clark, W., Cohen, G., De Deyn, P. P., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00924.x · Cited by 1,720
Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease
Tukey, R. H., & Strassburg, C. P. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.581 · Cited by 1,523
Bosma, P. J., Chowdhury, J. R., Bakker, C., Gantla, S., de Boer, A., Oostra, B. A., Lindhout, D., Tytgat, G. N. J., Jansen, P. L. M., Elferink, R. P. J. O., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511023331802 · Cited by 1,447
Ingelman-Sundberg, M., Sim, S. C., Gomez, A., & Rodriguez-Antona, C. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.09.004 · Cited by 1,166
Williams, J. A., Hyland, R., Jones, B. C., Smith, D. A., Hurst, S., Goosen, T. C., Peterkin, V., Koup, J. R., & Ball, S. E. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000794 · Cited by 928
Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily
Mackenzie, P. I., Walter Bock, K., Burchell, B., Guillemette, C., Ikushiro, S.-I., Iyanagi, T., Miners, J. O., Owens, I. S., & Nebert, D. W. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000173483.13689.56 · Cited by 821
Self-citationUDP-glucuronosyltransferases and clinical drug-drug interactions
KIANG, T., ENSOM, M., & CHANG, T. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.10.013 · Cited by 552
STRUCTURAL AND FUNCTIONAL STUDIES OF UDP-GLUCURONOSYLTRANSFERASES*
RADOMINSKA-PANDYA, A., CZERNIK, P. J., LITTLE, J. M., BATTAGLIA, E., & MACKENZIE, P. I. (1999) · Drug Metabolism Reviews · doi:10.1081/dmr-100101944 · Cited by 497
Self-citationBosma, P. J., Seppen, J., Goldhoorn, B., Bakker, C., Oude Elferink, R. P., Chowdhury, J. R., Chowdhury, N. R., & Jansen, P. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32403-1 · Cited by 446
Ohno, S., & Nakajin, S. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.023598 · Cited by 428
Glucuronidation in Humans: Pharmacogenetic and Developmental Aspects
de Wildt, S. N., Kearns, G. L., Leeder, J. S., & van den Anker, J. N. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936060-00005 · Cited by 393
Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite.
Paul, D., Standifer, K. M., Inturrisi, C. E., & Pasternak, G. W. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20832-1 · Cited by 393
What Do Medicinal Chemists Actually Make? A 50-Year Retrospective
Walters, W. P., Green, J., Weiss, J. R., & Murcko, M. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200504p · Cited by 387
Sugatani, J., Kojima, H., Ueda, A., Kakizaki, S., Yoshinari, K., Gong, Q.-H., Owens, I. S., Negishi, M., & Sueyoshi, T. (2001) · Hepatology · doi:10.1053/jhep.2001.24172 · Cited by 381
Drug glucuronidation in humans
Miners, J. O., & Mackenzie, P. I. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90065-t · Cited by 361
Self-citationWeiss, C. F., Glazko, A. J., & Weston, J. K. (1960) · New England Journal of Medicine · doi:10.1056/nejm196004212621601 · Cited by 352
Burchell, B., & Coughtrie, M. W. H. (1989) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(89)90122-8 · Cited by 346
Uchaipichat, V., Mackenzie, P. I., Guo, X.-H., Gardner-Stephen, D., Galetin, A., Houston, J. B., & Miners, J. O. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.4.413 · Cited by 335
Self-citationAntidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320
Ichikawa, S., Sakiyama, H., Suzuki, G., Hidari, K. I., & Hirabayashi, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4638 · Cited by 315
Rae, J. M., Johnson, M. D., Lippman, M. E., & Flockhart, D. A. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29202-8 · Cited by 306
Developmental aspects of human hepatic drug glucuronidation in young children and adults
Strassburg, C. P., Strassburg, A., Kneip, S., Barut, A., Tukey, R. H., Rodeck, B., & Manns, M. P. (2002) · Gut · doi:10.1136/gut.50.2.259 · Cited by 288
STRUCTURE AND FUNCTION OF URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASES
Meech, R., & Mackenzie, P. I. (1997) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1997.tb02718.x · Cited by 264
Self-citationCourt, M. H., Krishnaswamy, S., Hao, Q., Duan, S. X., Patten, C. J., von Moltke, L. L., & Greenblatt, D. J. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.9.1125 · Cited by 251
Kawade, N., & Onishi, S. (1981) · Biochemical Journal · doi:10.1042/bj1960257 · Cited by 247
Bhasker, C. R., McKinnon, W., Stone, A., Lo, A. C., Kubota, T., Ishizaki, T., & Miners, J. O. (2000) · Pharmacogenetics · doi:10.1097/00008571-200011000-00002 · Cited by 245
Self-citationSenafi, S. B., Clarke, D. J., & Burchell, B. (1994) · Biochemical Journal · doi:10.1042/bj3030233 · Cited by 238
Izukawa, T., Nakajima, M., Fujiwara, R., Yamanaka, H., Fukami, T., Takamiya, M., Aoki, Y., Ikushiro, S.-I., Sakaki, T., & Yokoi, T. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.027227 · Cited by 230
Bernard, O., & Guillemette, C. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.8.775 · Cited by 228
Miners, J. O., Knights, K. M., Houston, J. B., & Mackenzie, P. I. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.019 · Cited by 228
Self-citationMiners, J. O., Mackenzie, P. I., & Knights, K. M. (2010) · Drug Metabolism Reviews · doi:10.3109/03602530903210716 · Cited by 226
Self-citationSpecificity of human UDP-Glucuronosyltransferases and xenobiotic glucuronidation
Burchell, B., Brierley, C. H., & Rance, D. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02073-r · Cited by 224
Rowland, A., Elliot, D. J., Williams, J. A., Mackenzie, P. I., Dickinson, R. G., & Miners, J. O. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.009340 · Cited by 224
Self-citationCourt, M. H. (2010) · Drug Metabolism Reviews · doi:10.3109/03602530903209288 · Cited by 222
Isoform‐Selective Probe Substrates for In Vitro Studies of Human UDP‐Glucuronosyltransferases
Court, M. H. (2005) · Methods in Enzymology · doi:10.1016/s0076-6879(05)00007-8 · Cited by 217
Size, Myths and the Clinical Pharmacokinetics of Analgesia in Paediatric Patients
Anderson, B. J., McKee, A. D., & Holford, N. H. G. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199733050-00001 · Cited by 210
Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance
Miners, J. O., McKinnon, R. A., & Mackenzie, P. I. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00449-3 · Cited by 210
Self-citationMiners, J. O., Smith, P. A., Sorich, M. J., McKinnon, R. A., & Mackenzie, P. I. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121546 · Cited by 210
Self-citationKnights, K. M., Rowland, A., & Miners, J. O. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12086 · Cited by 207
Self-citationBarbier, O., Torra, I. P., Sirvent, A., Claudel, T., Blanquart, C., Duran-Sandoval, D., Kuipers, F., Kosykh, V., Fruchart, J.-C., & Staels, B. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00388-3 · Cited by 204
Miley, M. J., Zielinska, A. K., Keenan, J. E., Bratton, S. M., Radominska-Pandya, A., & Redinbo, M. R. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.03.066 · Cited by 198
Court, M. H., Zhang, X., Ding, X., Yee, K. K., Hesse, L. M., & Finel, M. (2012) · Xenobiotica · doi:10.3109/00498254.2011.618954 · Cited by 193
Yamamoto, K., Satō, H., Fujiyama, Y., Doida, Y., & Bamba, T. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(98)00013-1 · Cited by 191
Fatal Cardiovascular Collapse of Infants Receiving Large Amounts of Chloramphenicol
SUTHERLAND, J. M. (1959) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1959.02070010763001 · Cited by 189
Villeneuve, L., Girard, H., Fortier, L.-C., Gagné, J.-F., & Guillemette, C. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.054072 · Cited by 186
Rowland, A., Knights, K. M., Mackenzie, P. I., & Miners, J. O. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.021105 · Cited by 179
Self-citationUchaipichat, V., Winner, L. K., Mackenzie, P. I., Elliot, D. J., Williams, J. A., & Miners, J. O. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02588.x · Cited by 178
Self-citationCourt, M. H., Duan, S. X., Guillemette, C., Journault, K., Krishnaswamy, S., von Moltke, L. L., & Greenblatt, D. J. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.11.1257 · Cited by 174
Rowland, A., Gaganis, P., Elliot, D. J., Mackenzie, P. I., Knights, K. M., & Miners, J. O. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.118216 · Cited by 167
Self-citationEhmer, U., Vogel, A., Schütte, J. K., Krone, B., Manns, M. P., & Strassburg, C. P. (2004) · Hepatology · doi:10.1002/hep.20131 · Cited by 167
Holthe, M., Rakvåg, T. N., Klepstad, P., Idle, J. R., Kaasa, S., Krokan, H. E., & Skorpen, F. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500139 · Cited by 163
Nrf2-Keap1 Signaling Pathway Regulates Human UGT1A1 Expression in Vitro and in Transgenic UGT1 Mice
Yueh, M., & Tukey, R. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610790200 · Cited by 163
Gardner-Stephen, D., Heydel, J.-M., Goyal, A., Lu, Y., Xie, W., Lindblom, T., Mackenzie, P., & Radominska-Pandya, A. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.3.340 · Cited by 160
Self-citationCharacterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15
Wilson, W., de Villena, F. P., Lyn‐Cook, B. D., Chatterjee, P. K., Bell, T. A., Detwiler, D. A., Gilmore, R. C., Valladeras, I. C., Wright, C. C., Threadgill, D. W., et al. (2004) · Genomics · doi:10.1016/j.ygeno.2004.06.011 · Cited by 156
Expression and Characterization of Recombinant Human UDP-glucuronosyltransferases (UGTs)
Kurkela, M. J., Garcia-Horsman, A., Luukkanen, L., Mörsky, S., Taskinen, J., Baumann, M., Kostiainen, R. K., Hirvonen, J. J., & Finel, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206136200 · Cited by 154
Duguay, Y., Báár, C., Skorpen, F., & Guillemette, C. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.10.006 · Cited by 149
Diverse Actions and Target-Site Selectivity of Neonicotinoids: Structural Insights
Matsuda, K., Kanaoka, S., Akamatsu, M., & Sattelle, D. B. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.055186 · Cited by 149
Peer, C. J., Sissung, T. M., Kim, A., Jain, L., Woo, S., Gardner, E. R., Kirkland, C. T., Troutman, S. M., English, B. C., Richardson, E. D., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2484 · Cited by 148
Barbier, O., Durán-Sandoval, D., Pineda‐Torra, I., Kosykh, V., Fruchart, J., & Staels, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305361200 · Cited by 145
UGT genomic diversity: beyond gene duplication
Guillemette, C., Lévesque, É., Harvey, M., Bellemare, J., & Ménard, V. (2009) · Drug Metabolism Reviews · doi:10.3109/03602530903210682 · Cited by 140
Free Drug Metabolic Clearance in Elderly People
Butler, J. M., & Begg, E. J. (2008) · Clinical Pharmacokinetics · doi:10.2165/00003088-200847050-00002 · Cited by 137
Barbier, O., Villeneuve, L., Bocher, V., Fontaine, C., Pineda‐Torra, I., Duhem, C., Kosykh, V., Fruchart, J., Guillemette, C., & Staels, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300749200 · Cited by 129
Regulation of UDP Glucuronosyltransferase Genes
Mackenzie, P. I., Gregory, P. A., Gardner-Stephen, D. A., et al. (2003) · Current Drug Metabolism · doi:10.2174/1389200033489442 · Cited by 129
Self-citation“Phase I and Phase II” Drug Metabolism: Terminology that we Should Phase Out?
Josephy, P. D., Guengerich, F. P., & Miners, J. O. (2005) · Drug Metabolism Reviews · doi:10.1080/03602530500251220 · Cited by 128
Self-citationProtein−Protein Interactions between UDP-Glucuronosyltransferase Isozymes in Rat Hepatic Microsomes
Ikushiro, S., Emi, Y., & Iyanagi, T. (1997) · Biochemistry · doi:10.1021/bi9702344 · Cited by 123
Pfeffer, M. (1975) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600641045 · Cited by 120
Senekeo‐Effenberger, K., Chen, S., Brace‐Sinnokrak, E., Bonzo, J. A., Yueh, M., Argikar, U. A., Kaeding, J., Trottier, J., Remmel, R. P., Ritter, J. K., et al. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.013243 · Cited by 119
UDP-Glucuronosyltransferase, the Role of the Amino Terminus in Dimerization
Meech, R., & Mackenzie, P. I. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.26913 · Cited by 117
Self-citationMackenzie, P. I. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47997-5 · Cited by 116
Self-citationCharacterization of Two UDP Glucuronosyltransferases That Are Predominantly Expressed in Human Colon
Mojarrabi, B., & Mackenzie, P. I. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8843 · Cited by 112
Self-citationThe glucuronidation of mycophenolic acid by human liver, kidney and jejunum microsomes
Bowalgaha, K., & Miners, J. O. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01487.x · Cited by 109
Self-citationKrishnaswamy, S., Hao, Q., Al-Rohaimi, A., Hesse, L. M., Moltke, L. L., Greenblatt, D. J., & Court, M. H. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.081968 · Cited by 108
Sugatani, J., Yamakawa, K., Tonda, E., Nishitani, S., Yoshinari, K., Degawa, M., Abe, I., Noguchi, H., & Miwa, M. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.11.002 · Cited by 107
Polymorphisms in UDP Glucuronosyltransferase Genes: Functional Consequences and Clinical Relevance
Mackenzie, P. I., Miners, J. O., & McKinnon, R. A. (2000) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2000.129 · Cited by 106
Self-citationChung, J., Cho, J., YU, K., Kim, J., Jung, H., Lim, K. S., Jang, I., & Shin, S. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.02.006 · Cited by 105
The Development of UDP-Glucuronosyltransferases 1A1 and 1A6 in the Pediatric Liver
Miyagi, S. J., & Collier, A. C. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.037192 · Cited by 102
Bosio, A., Binczek, E., Beau, M. M. L., et al. (1996) · Genomics · doi:10.1006/geno.1996.0242 · Cited by 99
Development of multiple activities of UDP-glucuronyltransferase in human liver
Leakey, J. E. A., Hume, R., & Burchell, B. (1987) · Biochemical Journal · doi:10.1042/bj2430859 · Cited by 98
Sahai, J. V., Gallicano, K., Pakuts, A. P., & Cameron, D. W. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.5.1103 · Cited by 98
Udomuksorn, W., Elliot, D. J., Lewis, B. C., Mackenzie, P. I., Yoovathaworn, K., & Miners, J. O. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328256b1b6 · Cited by 97
Self-citationIdentification of UDP Glycosyltransferase 3A1 as a UDP N-Acetylglucosaminyltransferase
Mackenzie, P. I., Rogers, A., Treloar, J., Jorgensen, B. R., Miners, J. O., & Meech, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807961200 · Cited by 96
Self-citationGhosh, S. S., Sappal, B. S., Kalpana, G. V., Lee, S. W., Chowdhury, J. R., & Chowdhury, N. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106742200 · Cited by 93
Epirubicin Glucuronidation and UGT2B7 Developmental Expression
Zaya, M. J., Hines, R. N., & Stevens, J. C. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.011387 · Cited by 92
Polasek, T. M., Lin, F. P. Y., Miners, J. O., & Doogue, M. P. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.03903.x · Cited by 91
Self-citationCaraco, Y., Sheller, J. R., & Wood, A. J. J. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34915-8 · Cited by 91
Chung, J., Cho, J.-Y., Yu, K., Kim, J.-R., Lim, K., Sohn, D.-R., Shin, S.-G., & Jang, I.-J. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100324 · Cited by 90
Jinno, H., Saeki, M., Saito, Y., Tanaka‐Kagawa, T., Hanioka, N., Sai, K., Kaniwa, N., Ando, M., Shirao, K., Minami, H., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051250 · Cited by 87
Tsoutsikos, P., Miners, J. O., Stapleton, A. M. F., Thomas, A., Sallustio, B. C., & Knights, K. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.08.025 · Cited by 86
Self-citationZhang, X., Zhang, Q.-Y., Liu, D., Su, T., Weng, Y., Ling, G., Chen, Y., Gu, J., Schilling, B., & Ding, X. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005769 · Cited by 82
The Novel UDP Glycosyltransferase 3A2: Cloning, Catalytic Properties, and Tissue Distribution
Mackenzie, P. I., Rogers, A., Elliot, D. J., Chau, N., Hulin, J.-A., Miners, J. O., & Meech, R. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.069336 · Cited by 76
Self-citationMackenzie, P. I., Hu, D. G., & Gardner-Stephen, D. A. (2009) · Drug Metabolism Reviews · doi:10.3109/03602530903209544 · Cited by 75
Self-citationHe, X., Hesse, L. M., Hazarika, S., Masse, G., Harmatz, J. S., Greenblatt, D. J., & Court, M. H. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03519.x · Cited by 75
Six novel UDP-glucuronosyltransferase (UGT1A3) polymorphisms with varying activity
Iwai, M., Maruo, Y., Ito, M., Yamamoto, K., Sato, H., & Takeuchi, Y. (2004) · Journal of Human Genetics · doi:10.1007/s10038-003-0119-y · Cited by 75
Jin, C.-J., Mackenzie, P. I., & Miners, J. O. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.9949 · Cited by 75
Self-citationIshii, Y., Hansen, A. J., & Mackenzie, P. I. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26503-2 · Cited by 75
Self-citationVerreault, M., Senekeo‐Effenberger, K., Trottier, J., Bonzo, J. A., Bélanger, J., Kaeding, J., Staels, B., Caron, P., Tukey, R. H., & Barbier, O. (2006) · Hepatology · doi:10.1002/hep.21259 · Cited by 73
Ishii, Y., Hansen, A. J., & Mackenzie, P. I. (2000) · PubMed · Cited by 72
Self-citationComparison of paracetamol metabolism in young adult and elderly males
Miners, J. O., Penhall, R. K., Robson, R., & Birkett, D. J. (1988) · European Journal of Clinical Pharmacology · doi:10.1007/bf00609245 · Cited by 71
Self-citationGregory, P. A., Lewinsky, R., Gardner-Stephen, D. A., et al. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.953 · Cited by 71
Knights, K. M., Winner, L. K., Elliot, D. J., Bowalgaha, K., & Miners, J. O. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03469.x · Cited by 70
Self-citationIshii, Y., Miyoshi, A., Watanabe, R., Tsuruda, K., Tsuda, M., Yamaguchi-Nagamatsu, Y., Yoshisue, K., Tanaka, M., Maji, D., Ohgiya, S., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.5.1040 · Cited by 70
Uchaipichat, V., Galetin, A., Houston, J. B., Mackenzie, P. I., Williams, J. A., & Miners, J. O. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.048645 · Cited by 69
Self-citationBernard, P., Goudonnet, H., Artur, Y., Desvergne, B., & Wahli, W. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.3.526 · Cited by 67
Sun, D., Chen, G., Dellinger, R. W., Sharma, A. K., & Lazarus, P. J. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833b04af · Cited by 62
Kaeding, J., Bouchaert, E., Bélanger, J., Caron, P., Chouinard, S., Verreault, M., Larouche, O., Pelletier, G., Staels, B., Bélanger, A., et al. (2008) · Biochemical Journal · doi:10.1042/bj20071136 · Cited by 60
Lu, Y. F., Heydel, J., Li, X., Bratton, S. M., Lindblom, T. H., & Radominska-p, A. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.003061 · Cited by 58
Neonatal Development of Hepatic UGT1A9: Implications of Pediatric Pharmacokinetics
Miyagi, S. J., Milne, A., Coughtrie, M. W. H., & Collier, A. C. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.043752 · Cited by 52
Bowalgaha, K., Elliot, D. J., Mackenzie, P. I., Knights, K. M., & Miners, J. O. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.013052 · Cited by 52
Self-citationCoetzee, T., Li, X., Fujita, N., et al. (1996) · Genomics · doi:10.1006/geno.1996.0341 · Cited by 49
Hu, D. G., & Mackenzie, P. I. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.057380 · Cited by 48
Self-citationGlucosidation of hyodeoxycholic acid by UDP-glucuronosyltransferase 2B7
Mackenzie, P. I., Little, J. M., & Radomińska‐Pandya, A. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01522-8 · Cited by 47
Self-citationWang, Y.-H., Trucksis, M., McElwee, J. J., Wong, P. H., Maciolek, C. M., Thompson, C. D., Prueksaritanont, T., Garrett, G. C., Declercq, R., Vets, E., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.20 · Cited by 46
Lankisch, T. O., Gillman, T. C., Erichsen, T. J., Ehmer, U., Kalthoff, S., Freiberg, N., Münzel, P., Manns, M. P., & Strassburg, C. P. (2008) · Archives of Toxicology · doi:10.1007/s00204-008-0347-1 · Cited by 45
Radominska-p, A., Little, J., Pyrek, J. S., Drake, R. R., Igari, Y., Fournel‐Gigleux, S., Magdalou, J., Burchell, B., Elbein, A. D., & Siest, G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82446-2 · Cited by 44
Gaganis, V., Miners, J. O., Brennan, J. S., Thomas, A., & Knights, K. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.128603 · Cited by 44
Self-citationGardner-Stephen, D. A., & Mackenzie, P. I. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32801112b5 · Cited by 37
Self-citationSorich, M. J., McKinnon, R. A., Miners, J. O., & Smith, P. A. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci600248e · Cited by 37
Self-citationCalcitrol (1α,25-dihydroxyvitamin D3) inhibits androgen glucuronidation in prostate cancer cells
Kaeding, J., Bélanger, J., Caron, P., Verreault, M., Bélanger, A., & Barbier, O. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0455 · Cited by 35
Mays, D. C., Dixon, K., Balboa, A., Pawluk, L. J., Bauer, M., Nawoot, S., & Gerber, N. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20528-6 · Cited by 33
Hu, D. G., Gardner-Stephen, D. A., Severi, G., Gregory, P. A., Treloar, J., Giles, G. G., English, D. R., Hopper, J. L., Tilley, W. D., & Mackenzie, P. I. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.065953 · Cited by 32
Self-citationLewis, B. C., Mackenzie, P. I., & Miners, J. O. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.09.007 · Cited by 32
Self-citationGardner-Stephen, D. A., & Mackenzie, P. I. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012203 · Cited by 32
Self-citationTissue specific differences in the regulation of the UDP glucuronosyltransferase 2B17 gene promoter
Gregory, P. A., Hansen, A. J., & Mackenzie, P. I. (2000) · Pharmacogenetics · doi:10.1097/00008571-200012000-00006 · Cited by 31
Self-citationPharmacokinetic interaction of fluconazole and zidovudine in HIV-positive patients.
Brockmeyer, N. H., Tillmann, I., Mertins, L., Barthel, B., & Goos, M. (1997) · PubMed · Cited by 26
Shiraga, T., Yajima, K., Suzuki, K., Suzuki, K., Hashimoto, T., Iwatsubo, T., Miyashita, A., & Usui, T. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.042614 · Cited by 26
Hu, D. G., & Mackenzie, P. I. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035436 · Cited by 24
Self-citationGregory, P. A., Gardner-Stephen, D. A., Rogers, A., Michael, M., & Mackenzie, P. I. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000215068.06471.35 · Cited by 23
Self-citationGu, Y., Tingle, M. D., & Wilson, W. R. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.180703 · Cited by 23
Knights, K., Bowalgaha, K., & Miners, J. O. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.032870 · Cited by 11
Self-citationMackenzie, P. I., Gardner-Stephen, D. A., & Miners, J. O. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00420-6 · Cited by 11
Self-citation
Cited by
Hayes, J. D., Dinkova-Kostova, A. T., & Tew, K. D. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.06.001 · Cited by 2,654
Proteomic and Metabolomic Characterization of COVID-19 Patient Sera
Shen, B., Yi, X., Sun, Y., Bi, X., Du, J., Zhang, C., Quan, S., Zhang, F., Sun, R., Qian, L., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.032 · Cited by 1,514
Eelen, G., de Zeeuw, P., Treps, L., Harjes, U., Wong, B. W., & Carmeliet, P. (2018) · Physiological Reviews · doi:10.1152/physrev.00001.2017 · Cited by 572
Disease-induced changes in plant microbiome assembly and functional adaptation
Gao, M., Xiong, C., Gao, C., Tsui, C. K. M., Wang, M.-M., Zhou, X., Zhang, A.-M., & Cai, L. (2021) · Microbiome · doi:10.1186/s40168-021-01138-2 · Cited by 478
The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel Paradigms
Meech, R., Hu, D. G., McKinnon, R. A., Mubarokah, S. N., Haines, A. Z., Nair, P. C., Rowland, A., & Mackenzie, P. I. (2019) · Physiological Reviews · doi:10.1152/physrev.00058.2017 · Cited by 368
Self-citation
Metadata
- Authors
- Rowland, A., Miners, J. O., & Mackenzie, P. I.
- Venue
- The International Journal of Biochemistry & Cell Biology
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 45
- Issue
- 6
- Pages
- 1121-1132
- ISSN
- 1357-2725 (ISSN-L)
- OpenAlex
- W2016623506
- Cited by
- 709
- References
- 133
- FWCI
- 50.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.